Proskauer Advises Sixth Street on $500 Million Senior Secured Credit Facility with Beam Therapeutics

"Proskauer advised Sixth Street on a senior secured credit facility of up to $500 million with Beam Therapeutics Inc., providing long-term, non-dilutive capital to support the potential launch of ristoglogene autogetemcel (risto-cel) for sickle cell disease."

Proskauer advised Sixth Street on its entry into a senior secured credit facility with Beam Therapeutics Inc. (Nasdaq: BEAM). The transaction consists of a senior secured credit facility of up to $500 million between Sixth Street and Beam Therapeutics. The financing provides substantial, long-term, non-dilutive capital intended to fund the potential launch of ristoglogene autogetemcel (risto-cel) in sickle cell disease. Proskauer represented Sixth Street with a team composed by: partner Frederic L. Ragucci; associates Ashley A. Kerr and Nicole Foster (Private Credit & Leveraged Finance).

Read the full story

Already registered? Login

Menu

Proskauer Advises Sixth Street on $500 Million Senior Secured Credit Facility with Beam Therapeutics

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads